Navco Pharmaceuticals: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (NAV)
Navco Pharmaceuticals is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| CHS | Comprehensive Healthcare | 0.01 | 0.02 | 0.01 (218.0%) | 5238 | 0.6 | 0.0 | 0.0 |
| KOVO | Kovo+ Holdings | 0.04 | 0.12 | 0.07 (164.4%) | 10375 | 2.6 | 0.0 | 0.0 |
| QPT | Quest PharmaTech | 0.04 | 0.10 | 0.06 (157.1%) | 67981 | 6.8 | 0.0 | 0.0 |
| JNH | Jack Nathan Medical | 0.03 | 0.06 | 0.04 (141.0%) | 27460 | 2.2 | 0.0 | 0.0 |
| LFST | Lifeist Wellness | 0.04 | 0.10 | 0.06 (131.3%) | 45990 | 1.4 | 0.0 | 0.0 |
| DB | Decibel Cannabis Co | 0.06 | 0.13 | 0.07 (119.6%) | 393889 | 25.1 | 0.0 | 0.0 |
| PCLO | PharmaCielo | 0.08 | 0.16 | 0.08 (95.1%) | 150814 | 13.6 | 0.0 | 0.0 |
| ENTG | Entourage Health | 0.01 | 0.01 | 0.00 (88.6%) | 118845 | 1.5 | 0.0 | 0.0 |
| AVCR | Avricore Health | 0.06 | 0.10 | 0.04 (73.8%) | 352570 | 6.3 | 0.0 | 0.0 |
| NAV | Navco Pharmaceuticals | 0.02 | 0.03 | 0.01 (69.1%) | 36239 | 0.1 | 0.0 | 0.0 |
All data provided as of November 25, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Navco Pharmaceuticals
Navco Pharmaceuticals Inc uses nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. Its products have applications in the medical, personal care products, textile, chemical, and additive industries which are tailored to defend against microorganisms such as viruses, bacteria, fungi, and infectious diseases.
Navco Pharmaceuticals is listed under NAV on the TSX Venture Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
